arrow
H

Hugo Arasanz

servicio navarro de salud-osasunbidea
H指数:23
被引数:2,599

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group

可切除的III期非小细胞肺癌的定义:一项来自EORTC肺癌组的系统评价

2025-07-190
PRE
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study

西班牙早期可切除非小细胞肺癌患者中EGFR基因突变的发生率:ORIGEN研究

2025-04-010
OA
Indoor radon in patients with lung cancer in Spain: Preliminary data from the MIRROR study

西班牙肺癌患者室内氡水平:MIRROR研究的初步数据

2024-09-010
PRE
Circulating low-density neutrophils (LDNs) are associated with resistance to immunotherapy as frontline treatment for non-small cell lung cancer (NSCLC): Updated results and proteomic characterization

循环低密度中性粒细胞(LDNs)与非小细胞肺癌(NSCLC)一线免疫治疗抵抗相关:更新结果及蛋白质组学表征

2024-09-010
PRE
CBL-B inhibition overcomes PD-1/LAG-3 mediated resistance in lung cancer

CBL-B抑制克服了PD-1/LAG-3介导的肺癌耐药性

2024-09-010
PRE
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets

PD-1/LAG-3共信号分析揭示了CBL泛素连接酶作为关键的免疫治疗靶标

2024-07-192
OAAI
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain
2024-06-011
OAAI
ORIGEN: Multicenter study on the prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain
2023-10-010
OA
Cutting-Edge CAR Engineering: Beyond T Cells
2022-11-247
OAAI
CAR-T Cells for the Treatment of Lung Cancer

Car-t细胞治疗肺癌的研究进展

2022-04-0811
OAAI
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study

肺癌患者对SARS-CoV-2的血清阳性率和免疫记忆: 固体研究

2022-01-015
OAAI
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
2021-12-3012
OA